AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 201 filers reported holding AMICUS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $742 | -52.3% | 61 | -50.8% | 0.00% | – |
| Q2 2023 | $1,557 | -39.7% | 124 | -46.8% | 0.00% | – |
| Q1 2023 | $2,584 | -99.9% | 233 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $2,624,000 | -70.8% | 227,192 | -41.6% | 0.01% | -72.2% |
| Q4 2020 | $8,978,000 | +336.2% | 388,812 | +166.7% | 0.02% | +260.0% |
| Q3 2020 | $2,058,000 | -5.8% | 145,765 | +0.6% | 0.01% | 0.0% |
| Q2 2020 | $2,184,000 | +18100.0% | 144,858 | +16512.2% | 0.01% | – |
| Q1 2019 | $12,000 | +33.3% | 872 | -8.1% | 0.00% | – |
| Q4 2018 | $9,000 | -50.0% | 949 | -33.4% | 0.00% | – |
| Q3 2018 | $18,000 | -98.8% | 1,424 | -98.5% | 0.00% | -100.0% |
| Q2 2018 | $1,531,000 | +13818.2% | 98,031 | +13402.9% | 0.00% | – |
| Q1 2018 | $11,000 | -98.8% | 726 | -98.9% | 0.00% | -100.0% |
| Q4 2017 | $934,000 | -71.8% | 64,921 | -70.5% | 0.00% | -70.0% |
| Q3 2017 | $3,315,000 | – | 219,833 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |